Forefront Analytics, LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 13, 2026), Forefront Analytics, LLC reported 37 stock positions worth $92.0 million. Its top holding was Vanguard Ftse Emerging Marke (VWO) at 11.7% of the portfolio, followed by iShares Trust iShares ESG Aw (ESGD, 11.6%) and iShares Inc. iShares ESG Awar (ESGE, 11.4%). Compared with Q1 2026, it sold out of 2, added to 19 and reduced 15. The biggest buy was iShares MSCI USA Momentum Fa (MTUM, shares +1%) and the biggest sale iShares Trust iShares ESG Aw (ESGD, shares −59%).
- Most Recent 13F
- Q2 2026
- Location
- WEST CONSHOHOCKEN, PA
- CIK
- 0001696802
- Portfolio Value
- $92.0M (Q2 2026)
- SEC Filing
- 0001085146-26-000598 ↗ filed Aug 13, 2026
Holdings Value
Holdings 37 stocks · $92.0M
| VWO Vanguard Ftse Emerging Marke | 11.70% | 180,376 | $10.8M | Add +0.1% |
| ESGD iShares Trust iShares ESG Aw | 11.65% | 104,247 | $10.7M | Reduce -59.0% |
| ESGE iShares Inc. iShares ESG Awar | 11.43% | 192,398 | $10.5M | Reduce -47.9% |
| HDV iShares Core High Dividend E | 10.21% | 342,756 | $9.4M | Add +0.7% |
| MTUM iShares MSCI USA Momentum Fa | 9.10% | 24,434 | $8.4M | Add +0.8% |
| NULV Nuveen ESG Large-Cap Val ETF | 7.65% | 140,912 | $7.0M | Reduce -28.0% |
| DBEF Xtrackers MSCI Eafe Hedged E | 7.52% | 126,734 | $6.9M | Reduce -0.1% |
| ESGG NT Stoxx GLBL ESG ETF | 5.49% | 21,669 | $5.1M | Reduce -51.0% |
| NVDA Nvidia Corp. | 4.25% | 19,532 | $3.9M | Add +37.1% |
| VEA Vanguard Ftse Developed ETF | 3.68% | 47,559 | $3.4M | Add +0.5% |
| IVV iShares Core S&P 500 ETF | 3.62% | 4,450 | $3.3M | Reduce -0.5% |
| HEEM iShares Crncy Hedgd MSCI Em | 2.83% | 58,203 | $2.6M | Reduce -0.6% |
| JPM JPMorgan Chase & Co. | 1.78% | 4,997 | $1.6M | Add +0.3% |
| DE Deere & Co. | 0.81% | 1,172 | $743K | Add +3.2% |
| UNH Unitedhealth Group Inc. | 0.64% | 1,409 | $586K | Reduce -28.9% |
| INCY Incyte Corp. | 0.63% | 5,091 | $577K | Add +20.3% |
| EW Edwards Lifesciences Corp. | 0.61% | 6,158 | $557K | Reduce -6.3% |
| SSO Proshares Ultra S&P500 | 0.60% | 8,180 | $551K | Add +0.2% |
| UWM Proshares Ultra RUSSELL2000 | 0.58% | 7,997 | $538K | Add +0.1% |
| ABT Abbott Laboratories | 0.56% | 5,665 | $514K | Add +12.3% |
| EES Wisdomtree US Smallcap Fund | 0.52% | 7,020 | $476K | Reduce -14.7% |
| PFE Pfizer Inc. | 0.48% | 18,210 | $438K | Add +39.1% |
| MDT Medtronic PLC | 0.45% | 5,319 | $416K | No change |
| DHR Danaher Corp. | 0.42% | 2,040 | $389K | Add +58.4% |
| TMO Thermo Fisher Scientific Inc. | 0.36% | 669 | $336K | Add +15.5% |
| OTF Blue Owl Technology Finance | 0.33% | 29,654 | $307K | No change |
| LEGN Legend Biotech Corp.-ADR | 0.33% | 10,568 | $305K | Reduce -32.5% |
| PM Philip Morris International | 0.29% | 1,463 | $265K | Add +0.9% |
| REGN Regeneron Pharmaceuticals | 0.28% | 415 | $259K | Reduce -9.8% |
| SCHD Schwab US DVD Equity ETF | 0.26% | 7,676 | $243K | Reduce -49.2% |
| VTV Vanguard Mrngstr Val ETF-Aui | 0.26% | 1,084 | $236K | Reduce -17.7% |
| ZURA Zura Bio Ltd. | 0.17% | 26,968 | $159K | Add +81.0% |
| GERN Geron Corp. | 0.12% | 88,779 | $114K | Add +61.0% |
| CTMX Cytomx Therapeutics Inc. | 0.10% | 25,033 | $94K | Add +100.7% |
| BCYC Bicycle Therapeutics PLC-ADR | 0.10% | 21,822 | $93K | Add +51.6% |
| NKTX Nkarta Inc. | 0.09% | 28,955 | $82K | Reduce -34.0% |
| ANNX Annexon Inc. | 0.09% | 14,240 | $81K | No change |
Portfolio Sells Q1 2026 → Q2 2026
| ESGD iShares Trust iShares ESG Aw | Reduce -59.0% | 11.65% | −10.48 |
| ESGE iShares Inc. iShares ESG Awar | Reduce -47.9% | 11.43% | −3.84 |
| ESGG NT Stoxx GLBL ESG ETF | Reduce -51.0% | 5.49% | −2.55 |
| NULV Nuveen ESG Large-Cap Val ETF | Reduce -28.0% | 7.65% | −0.44 |
| DFSV Dimensional US Small Cap Val | Sold out | 0.00% | −0.20 |
| SCHD Schwab US DVD Equity ETF | Reduce -49.2% | 0.26% | −0.16 |
| REGN Regeneron Pharmaceuticals | Reduce -9.8% | 0.28% | −0.04 |
| MREO Mereo Biopharma Group PL-ADR | Sold out | 0.00% | −0.04 |
| NKTX Nkarta Inc. | Reduce -34.0% | 0.09% | +0.00 |
| VTV Vanguard Mrngstr Val ETF-Aui | Reduce -17.7% | 0.26% | +0.02 |
| LEGN Legend Biotech Corp.-ADR | Reduce -32.5% | 0.33% | +0.07 |
| EES Wisdomtree US Smallcap Fund | Reduce -14.7% | 0.52% | +0.08 |
| EW Edwards Lifesciences Corp. | Reduce -6.3% | 0.61% | +0.13 |
| UNH Unitedhealth Group Inc. | Reduce -28.9% | 0.64% | +0.15 |
| HEEM iShares Crncy Hedgd MSCI Em | Reduce -0.6% | 2.83% | +0.86 |
| IVV iShares Core S&P 500 ETF | Reduce -0.5% | 3.62% | +0.96 |
| DBEF Xtrackers MSCI Eafe Hedged E | Reduce -0.1% | 7.52% | +1.82 |
Portfolio Buys Q1 2026 → Q2 2026
| MTUM iShares MSCI USA Momentum Fa | Add +0.8% | 9.10% | +3.81 |
| VWO Vanguard Ftse Emerging Marke | Add +0.1% | 11.70% | +2.84 |
| NVDA Nvidia Corp. | Add +37.1% | 4.25% | +1.99 |
| HDV iShares Core High Dividend E | Add +0.7% | 10.21% | +1.80 |
| VEA Vanguard Ftse Developed ETF | Add +0.5% | 3.68% | +0.93 |
| JPM JPMorgan Chase & Co. | Add +0.3% | 1.78% | +0.44 |
| INCY Incyte Corp. | Add +20.3% | 0.63% | +0.26 |
| UWM Proshares Ultra RUSSELL2000 | Add +0.1% | 0.58% | +0.25 |
| DE Deere & Co. | Add +3.2% | 0.81% | +0.23 |
| SSO Proshares Ultra S&P500 | Add +0.2% | 0.60% | +0.21 |
| DHR Danaher Corp. | Add +58.4% | 0.42% | +0.20 |
| PFE Pfizer Inc. | Add +39.1% | 0.48% | +0.14 |
| TMO Thermo Fisher Scientific Inc. | Add +15.5% | 0.36% | +0.11 |
| ZURA Zura Bio Ltd. | Add +81.0% | 0.17% | +0.09 |
| ABT Abbott Laboratories | Add +12.3% | 0.56% | +0.09 |
| PM Philip Morris International | Add +0.9% | 0.29% | +0.07 |
| GERN Geron Corp. | Add +61.0% | 0.12% | +0.05 |
| CTMX Cytomx Therapeutics Inc. | Add +100.7% | 0.10% | +0.05 |
| BCYC Bicycle Therapeutics PLC-ADR | Add +51.6% | 0.10% | +0.04 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 37 | $92.0M | VWO, ESGD, ESGE, HDV, MTUM |
| Q1 2026 | 39 | $110.0M | ESGD, ESGE, VWO, HDV, NULV |
| Q4 2025 | 43 | $113.3M | ESGD, ESGE, MTUM, VWO, HDV |
| Q3 2025 | 43 | $103.8M | ESGD, NULV, MTUM, ESGE, VWO |
| Q2 2025Amended | 43 | $89.5M | NULV, MTUM, VWO, ESGD, VEA |
| Q1 2025 | 45 | $86.9M | NULV, SPYX, MTUM, VWO, VEA |
| Q4 2024 | 64 | $215.0M | NULV, BNDX, EMB, AOK, LTPZ |
| Q3 2024 | 67 | $212.0M | NULV, VWO, SPY, LTPZ, BNDX |
| Q2 2024 | 68 | $208.9M | NULV, VWO, SPY, LTPZ, BNDX |
| Q1 2024 | 67 | $206.2M | ESGD, NULV, VWO, SPY, LTPZ |